NO136094B - - Google Patents
Download PDFInfo
- Publication number
- NO136094B NO136094B NO1047/73A NO104773A NO136094B NO 136094 B NO136094 B NO 136094B NO 1047/73 A NO1047/73 A NO 1047/73A NO 104773 A NO104773 A NO 104773A NO 136094 B NO136094 B NO 136094B
- Authority
- NO
- Norway
- Prior art keywords
- amino
- ethanol
- phenyl
- compound
- dichloro
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 claims description 11
- 238000001640 fractional crystallisation Methods 0.000 claims description 11
- 150000003839 salts Chemical class 0.000 claims description 8
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 4
- KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical compound ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 claims description 4
- 125000004432 carbon atom Chemical group C* 0.000 claims description 4
- 229910052801 chlorine Inorganic materials 0.000 claims description 4
- 239000000460 chlorine Substances 0.000 claims description 4
- 150000007522 mineralic acids Chemical class 0.000 claims description 4
- 239000000203 mixture Substances 0.000 claims description 4
- 150000007524 organic acids Chemical class 0.000 claims description 4
- 235000005985 organic acids Nutrition 0.000 claims description 4
- 239000002253 acid Substances 0.000 claims description 3
- 238000000034 method Methods 0.000 claims description 3
- 230000001225 therapeutic effect Effects 0.000 claims description 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 2
- 229910052739 hydrogen Inorganic materials 0.000 claims description 2
- 239000001257 hydrogen Substances 0.000 claims description 2
- 125000000217 alkyl group Chemical group 0.000 claims 1
- 125000000753 cycloalkyl group Chemical group 0.000 claims 1
- 230000003287 optical effect Effects 0.000 claims 1
- 238000002360 preparation method Methods 0.000 claims 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 15
- 238000002844 melting Methods 0.000 description 15
- 230000008018 melting Effects 0.000 description 15
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 11
- 229940095064 tartrate Drugs 0.000 description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 9
- 230000000694 effects Effects 0.000 description 8
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 6
- 238000002425 crystallisation Methods 0.000 description 5
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- 239000002981 blocking agent Substances 0.000 description 4
- 230000000903 blocking effect Effects 0.000 description 4
- 230000008025 crystallization Effects 0.000 description 4
- ZOLBALGTFCCTJF-UHFFFAOYSA-N 4-[1-hydroxy-2-(propan-2-ylamino)ethyl]benzene-1,2-diol;sulfuric acid Chemical compound OS(O)(=O)=O.CC(C)NCC(O)C1=CC=C(O)C(O)=C1.CC(C)NCC(O)C1=CC=C(O)C(O)=C1 ZOLBALGTFCCTJF-UHFFFAOYSA-N 0.000 description 3
- 208000009079 Bronchial Spasm Diseases 0.000 description 3
- 208000014181 Bronchial disease Diseases 0.000 description 3
- 206010006482 Bronchospasm Diseases 0.000 description 3
- 230000008485 antagonism Effects 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000001990 intravenous administration Methods 0.000 description 3
- YONLFQNRGZXBBF-KBPBESRZSA-N (2s,3s)-2,3-dibenzoyloxybutanedioic acid Chemical compound O([C@H](C(=O)O)[C@H](OC(=O)C=1C=CC=CC=1)C(O)=O)C(=O)C1=CC=CC=C1 YONLFQNRGZXBBF-KBPBESRZSA-N 0.000 description 2
- 241000700198 Cavia Species 0.000 description 2
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 2
- 229960004373 acetylcholine Drugs 0.000 description 2
- 229910021529 ammonia Inorganic materials 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 230000001813 broncholytic effect Effects 0.000 description 2
- 238000013213 extrapolation Methods 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 229960001367 tartaric acid Drugs 0.000 description 2
- 239000011975 tartaric acid Substances 0.000 description 2
- 230000001960 triggered effect Effects 0.000 description 2
- AAWZDTNXLSGCEK-WYWMIBKRSA-N (-)-quinic acid Chemical compound O[C@@H]1C[C@](O)(C(O)=O)C[C@@H](O)[C@H]1O AAWZDTNXLSGCEK-WYWMIBKRSA-N 0.000 description 1
- MIOPJNTWMNEORI-GMSGAONNSA-N (S)-camphorsulfonic acid Chemical compound C1C[C@@]2(CS(O)(=O)=O)C(=O)C[C@@H]1C2(C)C MIOPJNTWMNEORI-GMSGAONNSA-N 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- 206010038687 Respiratory distress Diseases 0.000 description 1
- 208000001871 Tachycardia Diseases 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 230000001800 adrenalinergic effect Effects 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 229960001270 d- tartaric acid Drugs 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- MDKXBBPLEGPIRI-UHFFFAOYSA-N ethoxyethane;methanol Chemical compound OC.CCOCC MDKXBBPLEGPIRI-UHFFFAOYSA-N 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 229960002510 mandelic acid Drugs 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 235000011007 phosphoric acid Nutrition 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 230000006794 tachycardia Effects 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19722212600 DE2212600C3 (de) | 1972-03-16 | d- und l-1-(4-Amino-3,5-dichlorphenyl)-2-alkylamino-äthanole und deren Säureadditionssalze, Verfahren zu deren Herstellung sowie diese Verbindungen enthaltende Arzneimittel | |
| DE19732300614 DE2300614A1 (de) | 1973-01-08 | 1973-01-08 | Neue optisch aktive verbindungen |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO136094B true NO136094B (sv) | 1977-04-12 |
| NO136094C NO136094C (no) | 1977-07-20 |
Family
ID=25762898
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO1047/73A NO136094C (no) | 1972-03-16 | 1973-03-15 | Analogifremgangsm}te for fremstilling av terapeutisk aktive d-1-(4-amino-fenyl)-2-alkylamino-etanol-derivater. |
Country Status (17)
| Country | Link |
|---|---|
| JP (1) | JPS491528A (sv) |
| AT (1) | AT322534B (sv) |
| AU (1) | AU471457B2 (sv) |
| CH (1) | CH584184A5 (sv) |
| DD (1) | DD107260A5 (sv) |
| ES (1) | ES412615A1 (sv) |
| FI (1) | FI56523C (sv) |
| FR (1) | FR2181828B1 (sv) |
| GB (1) | GB1394542A (sv) |
| HU (1) | HU165270B (sv) |
| IL (1) | IL41784A0 (sv) |
| NL (1) | NL176669C (sv) |
| NO (1) | NO136094C (sv) |
| RO (1) | RO62876A (sv) |
| SE (1) | SE396597B (sv) |
| SU (1) | SU446963A3 (sv) |
| ZA (1) | ZA731796B (sv) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1523974A (en) * | 1975-02-05 | 1978-09-06 | Yamanouchi Pharma Co Ltd | 4-substituted amino- -aminomethylbenzyl alcohol derivatives |
| US4145363A (en) * | 1975-02-05 | 1979-03-20 | Yamanouchi Pharmaceutical Co., Ltd. | 4-Carbamoylamino-α-aminomethylbenzyl alcohol derivatives |
| US4063025A (en) | 1975-02-05 | 1977-12-13 | Yamanouchi Pharmaceutical Co., Ltd. | 4-Substituted amino-α-aminomethylbenzyl alcohol derivatives |
| JPS6191160A (ja) * | 1984-10-09 | 1986-05-09 | Nisshin Flour Milling Co Ltd | Ｌ−カルニチンの製造法 |
| US5059422A (en) * | 1985-07-29 | 1991-10-22 | American Cyanamid Company | Continuous release phenylethanolamine derivative compositions |
| US5169633A (en) * | 1985-07-29 | 1992-12-08 | American Cyanamid Company | Continuous release phenylethanolamine derivative compositions |
| US5530029A (en) * | 1987-09-15 | 1996-06-25 | The Rowett Research Institute | Therapeutic applications of clenbuterol |
| US5541188A (en) * | 1987-09-15 | 1996-07-30 | The Rowett Research Institute | Therapeutic applications of beta-adrenergic agonists |
| US6713651B1 (en) | 1999-06-07 | 2004-03-30 | Theravance, Inc. | β2-adrenergic receptor agonists |
| US6541669B1 (en) | 1998-06-08 | 2003-04-01 | Theravance, Inc. | β2-adrenergic receptor agonists |
| ZA994264B (en) | 1998-07-01 | 2000-01-25 | Warner Lambert Co | Stereoisomers with high affinity for adrenergic receptors. |
| US6593497B1 (en) | 1999-06-02 | 2003-07-15 | Theravance, Inc. | β2-adrenergic receptor agonists |
| US6683115B2 (en) | 1999-06-02 | 2004-01-27 | Theravance, Inc. | β2-adrenergic receptor agonists |
| US7232837B2 (en) | 1999-06-29 | 2007-06-19 | Mcneil-Ppc, Inc. | Stereoisomers with high affinity for adrenergic receptors |
| UA73965C2 (en) | 1999-12-08 | 2005-10-17 | Theravance Inc | b2 ADRENERGIC RECEPTOR ANTAGONISTS |
| OA11558A (en) * | 1999-12-08 | 2004-06-03 | Advanced Medicine Inc | Beta 2-adrenergic receptor agonists. |
| DE10328316A1 (de) | 2003-06-23 | 2005-01-20 | Grünenthal GmbH | Verfahren zur Herstellung von Dimethyl-(3-aryl-buthyl)-aminverbindungen als pharmazeutische Wirkstoffe |
| EP1754474A1 (en) * | 2005-02-02 | 2007-02-21 | Eucro European Contract Research GmbH & Co. KG | Use of S-Clenbuterol |
| DE102005052588A1 (de) | 2005-11-02 | 2007-05-10 | Grünenthal GmbH | Verfahren zur Herstellung substituierter Dimethyl-(3-aryl-butyl)-amin-Verbindungen mittels homogener Katalyse |
| TWI496762B (zh) | 2006-07-24 | 2015-08-21 | 製備（１ｒ，２ｒ）-３-（３-二甲胺基-１-乙基-２-甲基-丙基）-酚之方法 | |
| US8716350B2 (en) | 2010-03-30 | 2014-05-06 | Algynomics Inc. | Compositions and methods for the treatment of somatosensory disorders |
| EP2552433A4 (en) | 2010-03-30 | 2013-11-06 | Algynomics Inc | COMPOSITIONS AND METHODS OF TREATING SOMATOSENSORY DISEASES |
-
1973
- 1973-03-06 AT AT194573A patent/AT322534B/de not_active IP Right Cessation
- 1973-03-13 CH CH365773A patent/CH584184A5/xx not_active IP Right Cessation
- 1973-03-14 RO RO7300074162A patent/RO62876A/ro unknown
- 1973-03-14 ES ES412615A patent/ES412615A1/es not_active Expired
- 1973-03-14 SU SU1894116A patent/SU446963A3/ru active
- 1973-03-14 HU HUTO900A patent/HU165270B/hu unknown
- 1973-03-14 JP JP48029886A patent/JPS491528A/ja active Pending
- 1973-03-15 ZA ZA731796A patent/ZA731796B/xx unknown
- 1973-03-15 AU AU53345/73A patent/AU471457B2/en not_active Expired
- 1973-03-15 NO NO1047/73A patent/NO136094C/no unknown
- 1973-03-15 NL NLAANVRAGE7303612,A patent/NL176669C/xx not_active IP Right Cessation
- 1973-03-15 FI FI789/73A patent/FI56523C/fi active
- 1973-03-15 IL IL41784A patent/IL41784A0/xx unknown
- 1973-03-15 SE SE7303639A patent/SE396597B/sv unknown
- 1973-03-16 FR FR7309577A patent/FR2181828B1/fr not_active Expired
- 1973-03-16 GB GB1284273A patent/GB1394542A/en not_active Expired
- 1973-03-16 DD DD169508A patent/DD107260A5/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ES412615A1 (es) | 1976-01-01 |
| AU471457B2 (en) | 1976-04-29 |
| JPS491528A (sv) | 1974-01-08 |
| FR2181828A1 (sv) | 1973-12-07 |
| GB1394542A (en) | 1975-05-21 |
| NL176669C (nl) | 1985-05-17 |
| CH584184A5 (sv) | 1977-01-31 |
| SU446963A3 (ru) | 1974-10-15 |
| AU5334573A (en) | 1974-09-19 |
| RO62876A (fr) | 1977-10-15 |
| NL7303612A (sv) | 1973-09-18 |
| FI56523B (fi) | 1979-10-31 |
| NO136094C (no) | 1977-07-20 |
| FR2181828B1 (sv) | 1976-08-13 |
| ZA731796B (en) | 1974-11-27 |
| HU165270B (sv) | 1974-07-27 |
| FI56523C (fi) | 1980-02-11 |
| AT322534B (de) | 1975-05-26 |
| IL41784A0 (en) | 1973-05-31 |
| DD107260A5 (sv) | 1974-07-20 |
| NL176669B (nl) | 1984-12-17 |
| SE396597B (sv) | 1977-09-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO136094B (sv) | ||
| US4547508A (en) | 1-Phenylisoquinoline derivatives, pharmaceutical products containing these compounds and their use | |
| JPH03173867A (ja) | 環状アミン化合物 | |
| US3954872A (en) | 1-(2',6'-Dimethyl-phenoxy)-2-amino-alkanes and salts thereof | |
| US3183235A (en) | 1-[3-, 2-, and 1-indolyl-lower-alkanoyl] piperidines | |
| NO146432B (no) | Analogifremgangsmaate ved fremstilling av et dihydrokarbostyrilderivat | |
| DE3685604T2 (de) | 1,7-naphthyridinderivate und diese enthaltende arzneimittel. | |
| DE1643296A1 (de) | Mittel zur Behandlung bronchospastischer Erscheinungen | |
| DE1948144B2 (de) | 1 -(I -Keto-tetrahydronaphthyl-5-oxy) ^-hydroxy-S-alkylaminopropane, Verfahren zu ihrer Herstellung und pharmazeutische Zusammensetzung auf deren Basis | |
| US3456060A (en) | Therapeutic compositions containing piperidine derivatives and methods of treating cough and pain therewith | |
| AU3081792A (en) | Piperidine derivatives and their use in treating psychosis | |
| CA1161849A (en) | Derivatives of indole active on the cardiovascular system | |
| DE2313258A1 (de) | Verfahren zur herstellung von butyrophenonderivaten und ihren salzen neue butyrophenonderivate, ihre salze und diese verbindungen enthaltende arzneimittel | |
| US4304911A (en) | Benzoylphenyl lower alkanoyl piperidines | |
| DE69223769T2 (de) | Diphenylylchinuclidine als squalen-synthetase-inhibitoren | |
| US4339576A (en) | Anti-asthmatic, anti-allergic, anti-cholinergic, bronchodilator and anti-inflammatory 1-[(benzoylphenyl)-lower-alkyl]piperidines and analogs thereof | |
| DE2435169A1 (de) | 1-aryl-2- eckige klammer auf (subst.amino)alkanoyl eckige klammer zu -1,2,3,4-tetrahydroisochinoline | |
| CH649547A5 (de) | 1,2,4-oxadiazolin-5-on-derivate, ihre herstellung, sowie pharmazeutische mittel die solche derivate enthalten. | |
| US4076821A (en) | 4,4-Diphenylcycloalkylpiperidines and psychotropic compositions thereof | |
| LEE et al. | Piperidine derivatives. Part 1. Lobelan and related compounds | |
| EP0052311A1 (en) | 1-((Benzoylphenyl) - lower-alkyl) piperidines and carbinol analogs and preparation thereof | |
| US4010158A (en) | 1-(2'-Ethynyl-phenoxy)-2-hydroxy-3-butylamino-propanes and salts | |
| US3202674A (en) | Phenethylamine derivatives | |
| DE2061864B2 (de) | Acylderivate von substituierten Bis-Arylalkylaminen | |
| US3579512A (en) | 1-(4-piperidyl)-butanones |